David M. Epstein
2020
In 2020, David M. Epstein earned a total compensation of $3.9M as President and Chief Executive Officer at Black Diamond Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $270,400 |
|---|---|
| Option Awards | $3,030,428 |
| Salary | $507,825 |
| Other | $59,563 |
| Total | $3,868,216 |
Epstein received $3M in option awards, accounting for 78% of the total pay in 2020.
Epstein also received $270.4K in non-equity incentive plan, $507.8K in salary and $59.6K in other compensation.
Rankings
In 2020, David M. Epstein's compensation ranked 2,959th out of 13,090 executives tracked by ExecPay. In other words, Epstein earned more than 77.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,959 out of 13,090 | 77th |
Division Manufacturing | 1,151 out of 5,624 | 80th |
Major group Chemicals And Allied Products | 430 out of 2,257 | 81st |
Industry group Drugs | 373 out of 1,957 | 81st |
Industry Biological Products, Except Diagnostic Substances | 96 out of 411 | 77th |
Source: SEC filing on April 28, 2022.
Epstein's colleagues
We found one more compensation record of an executive who worked with David M. Epstein at Black Diamond Therapeutics in 2020.
2020
Brent Hatzis-Schoch
Black Diamond Therapeutics